If those are the requirements for inclusion and eI
Post# of 148190
(Total Views: 428)
Posted On: 01/01/2021 11:40:31 AM
If those are the requirements for inclusion and eIND, then placebo has the same restrictions... Would think it would result in more deaths in placebo. If anything I'd say it's ensuring that we're looking for effecacy in the extreme / critical. 3 doses would be nice, but benefit should still be seen with 2, considering.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼